• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Partial purification and characterization of keratokinase, the fibrinolytic activator of the cornea.

作者信息

Pandolfi M, Lantz E

出版信息

Exp Eye Res. 1979 Nov;29(5):563-71. doi: 10.1016/0014-4835(79)90156-8.

DOI:10.1016/0014-4835(79)90156-8
PMID:393529
Abstract
摘要

相似文献

1
Partial purification and characterization of keratokinase, the fibrinolytic activator of the cornea.
Exp Eye Res. 1979 Nov;29(5):563-71. doi: 10.1016/0014-4835(79)90156-8.
2
Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.具有增强纤维蛋白结合能力的重组嵌合纤溶酶原激活剂的特性分析
Biochim Biophys Acta. 2001 Apr 7;1546(2):399-405. doi: 10.1016/s0167-4838(01)00161-3.
3
Differences in the reactivities of human urokinase and the porcine tissue plasminogen activator.
Haemostasis. 1976;5(5):295-305. doi: 10.1159/000214148.
4
Characterization and partial purification of the plasminogen activator from human neuroblastoma cell line, SK-N-SH. A comparison with human urokinase.人神经母细胞瘤细胞系SK-N-SH纤溶酶原激活物的特性鉴定与部分纯化：与人类尿激酶的比较
Biochim Biophys Acta. 1982 Jun 24;704(3):450-60. doi: 10.1016/0167-4838(82)90067-x.
5
Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.在刺激尿激酶型蛋白合成和/或释放的情况下，尿激酶在正常人类受试者肠道中的转运。
J Clin Invest. 1985 Apr;75(4):1212-22. doi: 10.1172/JCI111818.
6
Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.不同于尿激酶的人肾纤溶酶原激活物的纯化及特性研究
Biochim Biophys Acta. 1982 Aug 6;717(2):327-36. doi: 10.1016/0304-4165(82)90187-8.
7
Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
Dan Med Bull. 1977 Oct;24(5):189-206.
8
Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase).
Semin Thromb Hemost. 1987 Apr;13(2):146-51. doi: 10.1055/s-2007-1003485.
9
Properties of three different molecular forms of the alpha 2 plasmin inhibitor.α2纤溶酶抑制剂三种不同分子形式的特性
Eur J Biochem. 1981 Nov;120(1):105-12. doi: 10.1111/j.1432-1033.1981.tb05675.x.
10
Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.从大鼠吉田腹水肉瘤中分离纯化纤溶酶原激活剂。
Indian J Biochem Biophys. 1991 Feb;28(1):46-51.

引用本文的文献

1
Role of protease-activated receptors 2 (PAR2) in ocular infections and inflammation.蛋白酶激活受体2（PAR2）在眼部感染和炎症中的作用。
Receptors Clin Investig. 2014;1(6). doi: 10.14800/rci.291.
2
The appearance and possible role of plasminogen activator of urokinase type (u-PA) activity in the cornea related to soft contact lens wear in rabbits.与兔眼软性隐形眼镜佩戴相关的角膜中尿激酶型纤溶酶原激活剂（u-PA）活性的表现及可能作用。
Doc Ophthalmol. 1998;95(2):165-79. doi: 10.1023/a:1001800130446.
3
Release of fibrinolytic activators from the cornea and conjunctiva.
纤维蛋白溶解激活剂从角膜和结膜的释放。
Graefes Arch Clin Exp Ophthalmol. 1982;219(6):263-7. doi: 10.1007/BF00231410.
4
Characterization and antithrombotic action of tissue plasminogen activator.
Experientia. 1984 Jan 15;40(1):67-8. doi: 10.1007/BF01959105.
5
Inflammatory mechanisms in corneal ulceration.角膜溃疡中的炎症机制。
Trans Am Ophthalmol Soc. 1985;83:610-63.
6
Fibrinolysis in cornea and conjunctiva: evidence of two types of activators.
Graefes Arch Clin Exp Ophthalmol. 1986;224(5):393-6. doi: 10.1007/BF02173351.
7
Tear plasminogen activators--indicators of epithelial cell destruction. The effect of scraping, n-heptanol debridement, and alkali burn of the cornea on the plasminogen activator activity of rabbit tears.泪液纤溶酶原激活剂——上皮细胞破坏的指标。刮伤、正庚醇清创术及角膜碱烧伤对兔泪液纤溶酶原激活剂活性的影响。
Int Ophthalmol. 1991 Nov;15(6):363-9. doi: 10.1007/BF00137946.